Trial Profile

Long Term Safety and Efficacy of Talcom Compared with Plavix in Patient with Acute Coronary Syndrome

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Aug 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary) ; Clopidogrel (Primary) ; Aspirin
Indications Acute coronary syndromes
Focus Pharmacodynamics

Most Recent Events

27 Aug 2018 New trial record
20 Aug 2018 Primary endpoint (Levels of PLADP by LTA on the 5th day and at 1 month after randomization) has been met published in the European Journal of Clinical Pharmacology.
20 Aug 2018 Results published in the European Journal of Clinical Pharmacology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com